Page last updated: 2024-10-22

acetyl-dl-leucine and Autosomal Dominant Cerebellar Ataxia, Type II

acetyl-dl-leucine has been researched along with Autosomal Dominant Cerebellar Ataxia, Type II in 1 studies

acetylleucine: used for treating vestibular-related imbalance and vertigo

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feil, K1
Adrion, C1
Teufel, J1
Bösch, S1
Claassen, J1
Giordano, I1
Hengel, H1
Jacobi, H1
Klockgether, T1
Klopstock, T1
Nachbauer, W1
Schöls, L1
Stendel, C1
Uslar, E1
van de Warrenburg, B1
Berger, I1
Naumann, I1
Bayer, O1
Müller, HH1
Mansmann, U1
Strupp, M1

Trials

1 trial available for acetyl-dl-leucine and Autosomal Dominant Cerebellar Ataxia, Type II

ArticleYear
Effects of acetyl-DL-leucine on cerebellar ataxia (ALCAT trial): study protocol for a multicenter, multinational, randomized, double-blind, placebo-controlled, crossover phase III trial.
    BMC neurology, 2017, Jan-10, Volume: 17, Issue:1

    Topics: Adult; Cerebellar Ataxia; Cross-Over Studies; Double-Blind Method; Humans; Leucine; Psychiatric Stat

2017